GOLGA3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.963200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.702800E-01
Normal-vs-Stage2
7.518400E-01
Normal-vs-Stage3
4.821400E-01
Normal-vs-Stage4
4.464000E-01
Stage1-vs-Stage2
2.482400E-01
Stage1-vs-Stage3
1.305590E-01
Stage1-vs-Stage4
8.224000E-01
Stage2-vs-Stage3
1.774600E-01
Stage2-vs-Stage4
1.835760E-01
Stage3-vs-Stage4
2.186200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.549400E-01
Normal-vs-AfricanAmerican
9.902600E-01
Normal-vs-Asian
7.810400E-01
Caucasian-vs-AfricanAmerican
5.366000E-01
Caucasian-vs-Asian
2.045800E-01
AfricanAmerican-vs-Asian
7.048400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.418800E-01
Normal-vs-Female
7.379600E-01
Male-vs-Female
8.885600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.463400E-01
Normal-vs-Age(41-60Yrs)
5.450000E-01
Normal-vs-Age(61-80Yrs)
7.933600E-01
Normal-vs-Age(81-100Yrs)
8.893200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.566200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.177600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.453400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.078550E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.479000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.159600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.909800E-01
Normal-vs-Daily Drinker
8.661600E-01
Normal-vs-Weekly Drinker
5.142600E-01
Normal-vs-Occasional Drinker
3.051000E-01
Normal-vs-Social Drinker
4.860800E-01
Non Drinker-vs-Daily Drinker
7.497600E-01
Non Drinker-vs-Weekly Drinker
2.658400E-01
Non Drinker-vs-Occasional Drinker
1.083160E-01
Non Drinker-vs-Social Drinker
1.414250E-01
Daily Drinker-vs-Weekly Drinker
4.019200E-01
Daily Drinker-vs-Occasional Drinker
1.927040E-01
Daily Drinker-vs-Social Drinker
1.856020E-01
Weekly Drinker-vs-Occasional Drinker
7.608800E-01
Weekly Drinker-vs-Social Drinker
3.790200E-01
Occasional Drinker-vs-Social Drinker
4.412400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.126400E-01
Normal-vs-Grade 2
7.978600E-01
Normal-vs-Grade 3
7.668800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.939000E-01
Grade 1-vs-Grade 3
4.519800E-01
Grade 1-vs-Grade 4
5.126400E-01
Grade 2-vs-Grade 3
5.404400E-01
Grade 2-vs-Grade 4
7.978600E-01
Grade 3-vs-Grade 4
7.668800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.484400E-01
Normal-vs-NonDiabetic
6.846600E-01
Diabetic-vs-NonDiabetic
4.267400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.027800E-01
Normal-vs-NoPancreatitis
7.224600E-01
Pancreatitis-vs-NoPancreatitis
7.011000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.433400E-01
Normal-vs-N1
7.896000E-01
N0-vs-N1
2.355800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.912000E-01
Normal-vs-TP53-NonMutant
6.298000E-01
TP53-Mutant-vs-TP53-NonMutant
9.592300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
